• OPEN AN ACCOUNT
Indian Indices
Nifty
25,910.05 30.90
(0.12%)
Sensex
84,562.78 84.11
( 0.10%)
Bank Nifty
58,517.55 135.60
( 0.23%)
Nifty IT
36,301.25 -378.20
( -1.03%)
Global Indices
Nasdaq
47,468.90 -806.92
(-1.67%)
Dow Jones
6,758.27 -113.65
(-1.65%)
Hang Seng
50,333.56 -948.27
(-1.85%)
Nikkei 225
9,693.83 -113.85
(-1.16%)
Forex
USD-INR
88.59 -0.09
(-0.10%)
EUR-INR
102.60 0.08
(0.08%)
GBP-INR
116.32 -0.42
(-0.36%)
JPY-INR
0.57 0.00
(-0.52%)

EQUITY - MARKET SCREENER

Kilitch Drugs (India) Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
524500
INE729D01010
173.2581804
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
KILITCH
20.17
643.47
EPS(TTM)
Face Value()
Div & Yield %
18.25
10
0
 

sylph technologies ltd
Johnson Pharmacare reports standalone net loss of Rs 0.51 crore in the March 2025 quarter
May 24,2025
Net loss of Johnson Pharmacare reported to Rs 0.51 crore in the quarter ended March 2025. There were no net profit/loss reported during the previous quarter ended March 2024. There were no Sales reported in the quarter ended March 2025 and during the previous quarter ended March 2024.

For the full year,net loss reported to Rs 0.58 crore in the year ended March 2025 as against net loss of Rs 0.20 crore during the previous year ended March 2024. There were no Sales reported in the year ended March 2025 and during the previous year ended March 2024.